Provided by Tiger Trade Technology Pte. Ltd.

Vivani Medical, Inc.

1.48
-0.0400-2.63%
Post-market: 1.39-0.0900-6.08%19:45 EST
Volume:216.95K
Turnover:329.77K
Market Cap:107.97M
PE:-3.35
High:1.55
Open:1.48
Low:1.48
Close:1.52
52wk High:1.92
52wk Low:0.9054
Shares:72.95M
Float Shares:36.07M
Volume Ratio:1.61
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4418
EPS(LYR):-0.4272
ROE:-265.02%
ROA:-50.05%
PB:82.48
PE(LYR):-3.46

Loading ...

Vivani Medical Inc - to Announce New Record Date Soon as Possible

THOMSON REUTERS
·
Oct 03

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

GlobeNewswire
·
Oct 03

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

GlobeNewswire
·
Sep 24

H.C. Wainwright Reaffirms Their Buy Rating on Vivani Medical (VANI)

TIPRANKS
·
Sep 18

Vivani Medical announces spin-off of Cortigent subsidiary

TIPRANKS
·
Sep 17

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

GlobeNewswire
·
Sep 17

Vivani Medical (VANI) Receives a Buy from Maxim Group

TIPRANKS
·
Sep 12

Vivani Medical Inc. Unveils Presentation on Innovative Obesity Treatment and Market Expansion Strategies

Reuters
·
Sep 10

BRIEF-Vivani Medical Provides Update On Clinical Development Plans For Npm-139 Semaglutide Implant For Chronic Weight Management

Reuters
·
Sep 04

Vivani Medical Inc - to Initiate Phase 1 Study for Npm-139 in 2026

THOMSON REUTERS
·
Sep 04

Vivani Medical Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 02

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

GlobeNewswire
·
Aug 20

Vivani Medical Inc. Unveils Investor Presentation Highlighting Innovative Drug Implants for Chronic Diseases

Reuters
·
Aug 15

Vivani Medical Q2 EPS $(0.12) Misses $(0.10) Estimate

Benzinga
·
Aug 14

Vivani Medical Inc - to Spin off Cortigent as Independent Public Company

THOMSON REUTERS
·
Aug 14

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

THOMSON REUTERS
·
Aug 14

Vivani Medical Inc: Securing Financial Position Into Second Half of 2026

THOMSON REUTERS
·
Aug 14

Vivani Medical Q2 Operating Expenses USD 7.462 Million

THOMSON REUTERS
·
Aug 14

BRIEF-Vivani Medical Announces Rapid Advancement Of NPM-139

Reuters
·
Aug 05

Vivani Medical Inc - Prioritizes Advancement of Npm-139, With Clinical Development Expected to Begin in 2026

THOMSON REUTERS
·
Aug 05